Cargando…
Development and Validation of Ischemic Events Related Signature After Carotid Endarterectomy
Background: Ischemic events after carotid endarterectomy (CEA) in carotid artery stenosis patients are unforeseeable and alarming. Therefore, we aimed to establish a novel model to prevent recurrent ischemic events after CEA. Methods: Ninety-eight peripheral blood mononuclear cell samples were colle...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8969028/ https://www.ncbi.nlm.nih.gov/pubmed/35372347 http://dx.doi.org/10.3389/fcell.2022.794608 |
_version_ | 1784679173278662656 |
---|---|
author | Guo, Chunguang Liu, Zaoqu Cao, Can Zheng, Youyang Lu, Taoyuan Yu, Yin Wang, Libo Liu, Long Liu, Shirui Hua, Zhaohui Han, Xinwei Li, Zhen |
author_facet | Guo, Chunguang Liu, Zaoqu Cao, Can Zheng, Youyang Lu, Taoyuan Yu, Yin Wang, Libo Liu, Long Liu, Shirui Hua, Zhaohui Han, Xinwei Li, Zhen |
author_sort | Guo, Chunguang |
collection | PubMed |
description | Background: Ischemic events after carotid endarterectomy (CEA) in carotid artery stenosis patients are unforeseeable and alarming. Therefore, we aimed to establish a novel model to prevent recurrent ischemic events after CEA. Methods: Ninety-eight peripheral blood mononuclear cell samples were collected from carotid artery stenosis patients. Based on weighted gene co-expression network analysis, we performed whole transcriptome correlation analysis and extracted the key module related to ischemic events. The biological functions of the 292 genes in the key module were annotated via GO and KEGG enrichment analysis, and the protein-protein interaction (PPI) network was constructed via the STRING database and Cytoscape software. The enrolled samples were divided into train (n = 66), validation (n = 28), and total sets (n = 94). In the train set, the random forest algorithm was used to identify critical genes for predicting ischemic events after CEA, and further dimension reduction was performed by LASSO logistic regression. A diagnosis model was established in the train set and verified in the validation and total sets. Furthermore, fifty peripheral venous blood samples from patients with carotid stenosis in our hospital were used as an independent cohort to validation the model by RT-qPCR. Meanwhile, GSEA, ssGSEA, CIBERSORT, and MCP-counter were used to enrichment analysis in high- and low-risk groups, which were divided by the median risk score. Results: We established an eight-gene model consisting of PLSCR1, ECRP, CASP5, SPTSSA, MSRB1, BCL6, FBP1, and LST1. The ROC-AUCs and PR-AUCs of the train, validation, total, and independent cohort were 0.891 and 0.725, 0.826 and 0.364, 0.869 and 0.654, 0.792 and 0.372, respectively. GSEA, ssGSEA, CIBERSORT, and MCP-counter analyses further revealed that high-risk patients presented enhanced immune signatures, which indicated that immunotherapy may improve clinical outcomes in these patients. Conclusion: An eight-gene model with high accuracy for predicting ischemic events after CEA was constructed. This model might be a promising tool to facilitate the clinical management and postoperative surveillance of carotid artery stenosis patients. |
format | Online Article Text |
id | pubmed-8969028 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-89690282022-04-01 Development and Validation of Ischemic Events Related Signature After Carotid Endarterectomy Guo, Chunguang Liu, Zaoqu Cao, Can Zheng, Youyang Lu, Taoyuan Yu, Yin Wang, Libo Liu, Long Liu, Shirui Hua, Zhaohui Han, Xinwei Li, Zhen Front Cell Dev Biol Cell and Developmental Biology Background: Ischemic events after carotid endarterectomy (CEA) in carotid artery stenosis patients are unforeseeable and alarming. Therefore, we aimed to establish a novel model to prevent recurrent ischemic events after CEA. Methods: Ninety-eight peripheral blood mononuclear cell samples were collected from carotid artery stenosis patients. Based on weighted gene co-expression network analysis, we performed whole transcriptome correlation analysis and extracted the key module related to ischemic events. The biological functions of the 292 genes in the key module were annotated via GO and KEGG enrichment analysis, and the protein-protein interaction (PPI) network was constructed via the STRING database and Cytoscape software. The enrolled samples were divided into train (n = 66), validation (n = 28), and total sets (n = 94). In the train set, the random forest algorithm was used to identify critical genes for predicting ischemic events after CEA, and further dimension reduction was performed by LASSO logistic regression. A diagnosis model was established in the train set and verified in the validation and total sets. Furthermore, fifty peripheral venous blood samples from patients with carotid stenosis in our hospital were used as an independent cohort to validation the model by RT-qPCR. Meanwhile, GSEA, ssGSEA, CIBERSORT, and MCP-counter were used to enrichment analysis in high- and low-risk groups, which were divided by the median risk score. Results: We established an eight-gene model consisting of PLSCR1, ECRP, CASP5, SPTSSA, MSRB1, BCL6, FBP1, and LST1. The ROC-AUCs and PR-AUCs of the train, validation, total, and independent cohort were 0.891 and 0.725, 0.826 and 0.364, 0.869 and 0.654, 0.792 and 0.372, respectively. GSEA, ssGSEA, CIBERSORT, and MCP-counter analyses further revealed that high-risk patients presented enhanced immune signatures, which indicated that immunotherapy may improve clinical outcomes in these patients. Conclusion: An eight-gene model with high accuracy for predicting ischemic events after CEA was constructed. This model might be a promising tool to facilitate the clinical management and postoperative surveillance of carotid artery stenosis patients. Frontiers Media S.A. 2022-03-17 /pmc/articles/PMC8969028/ /pubmed/35372347 http://dx.doi.org/10.3389/fcell.2022.794608 Text en Copyright © 2022 Guo, Liu, Cao, Zheng, Lu, Yu, Wang, Liu, Liu, Hua, Han and Li. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cell and Developmental Biology Guo, Chunguang Liu, Zaoqu Cao, Can Zheng, Youyang Lu, Taoyuan Yu, Yin Wang, Libo Liu, Long Liu, Shirui Hua, Zhaohui Han, Xinwei Li, Zhen Development and Validation of Ischemic Events Related Signature After Carotid Endarterectomy |
title | Development and Validation of Ischemic Events Related Signature After Carotid Endarterectomy |
title_full | Development and Validation of Ischemic Events Related Signature After Carotid Endarterectomy |
title_fullStr | Development and Validation of Ischemic Events Related Signature After Carotid Endarterectomy |
title_full_unstemmed | Development and Validation of Ischemic Events Related Signature After Carotid Endarterectomy |
title_short | Development and Validation of Ischemic Events Related Signature After Carotid Endarterectomy |
title_sort | development and validation of ischemic events related signature after carotid endarterectomy |
topic | Cell and Developmental Biology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8969028/ https://www.ncbi.nlm.nih.gov/pubmed/35372347 http://dx.doi.org/10.3389/fcell.2022.794608 |
work_keys_str_mv | AT guochunguang developmentandvalidationofischemiceventsrelatedsignatureaftercarotidendarterectomy AT liuzaoqu developmentandvalidationofischemiceventsrelatedsignatureaftercarotidendarterectomy AT caocan developmentandvalidationofischemiceventsrelatedsignatureaftercarotidendarterectomy AT zhengyouyang developmentandvalidationofischemiceventsrelatedsignatureaftercarotidendarterectomy AT lutaoyuan developmentandvalidationofischemiceventsrelatedsignatureaftercarotidendarterectomy AT yuyin developmentandvalidationofischemiceventsrelatedsignatureaftercarotidendarterectomy AT wanglibo developmentandvalidationofischemiceventsrelatedsignatureaftercarotidendarterectomy AT liulong developmentandvalidationofischemiceventsrelatedsignatureaftercarotidendarterectomy AT liushirui developmentandvalidationofischemiceventsrelatedsignatureaftercarotidendarterectomy AT huazhaohui developmentandvalidationofischemiceventsrelatedsignatureaftercarotidendarterectomy AT hanxinwei developmentandvalidationofischemiceventsrelatedsignatureaftercarotidendarterectomy AT lizhen developmentandvalidationofischemiceventsrelatedsignatureaftercarotidendarterectomy |